Advance in microRNA as a potential biomarker for early detection of pancreatic cancer

[1]  Frédérick A. Mallette,et al.  miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells. , 2016, Cell reports.

[2]  D. Metz,et al.  Consensus on biomarkers for neuroendocrine tumour disease. , 2015, The Lancet. Oncology.

[3]  M. Reni,et al.  MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets? , 2015, Oncotarget.

[4]  M. Büchler,et al.  Combined evaluation of a panel of protein and miRNA serum‐exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity , 2015, International journal of cancer.

[5]  M. Hidalgo,et al.  The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells , 2015, Gut.

[6]  Rong Wu,et al.  Diagnosis of pancreatic cancer using ¹⁸F-FDG PET/CT and CA19-9 with SUVmax association to clinical characteristics. , 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[7]  M. Korc,et al.  A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile , 2014, The American Journal of Gastroenterology.

[8]  S. Khan,et al.  Targeting Micrornas in Pancreatic Cancer: Microplayers in the Big Game Pancreatic Cancer and Mirna , 2022 .

[9]  Zuqiang Liu,et al.  CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer , 2013, Journal of Gastrointestinal Surgery.

[10]  R. Hruban,et al.  MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls , 2013, Clinical Cancer Research.

[11]  E. Giovannetti,et al.  The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  Y. Gong,et al.  Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer , 2012, International journal of cancer.

[13]  A. Adai,et al.  Global microRNA expression profiling of microdissected tissues identifies miR‐135b as a novel biomarker for pancreatic ductal adenocarcinoma , 2012, International journal of cancer.

[14]  M. Diederich,et al.  MicroRNAs in cancer management and their modulation by dietary agents. , 2012, Biochemical pharmacology.

[15]  Xi Chen,et al.  Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. , 2012, Clinical chemistry.

[16]  M. Duffy,et al.  Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  Ann M. Killary,et al.  MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease , 2009, Cancer Prevention Research.

[18]  K. Okita,et al.  Usefulness of endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of pancreatic cancer , 2005, Journal of Gastroenterology.

[19]  W. Schima,et al.  Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. , 2002, AJR. American journal of roentgenology.

[20]  M. Georgi,et al.  Wertigkeit von Magnetresonanztomographie (MRT), Magnetresonanz-Cholangiopankreatikographie (MRCP) und endoskopischer retrograder Cholangiopankreatikographie (ERCP) bei der Diagnose von Pankreastumoren , 1999 .

[21]  V. Dest,et al.  When the diagnosis is pancreatic cancer. , 1991, RN.

[22]  S. Batra,et al.  Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. , 2015, Advanced drug delivery reviews.

[23]  R. Mahato,et al.  miRNAs in pancreatic cancer: therapeutic potential, delivery challenges and strategies. , 2015, Advanced drug delivery reviews.